TP53 and cancer: Meanwhile, through inhibiting the release of TNF-α, NO, and other inflammatory mediators, and up-regulating P53 gene expression (Vipperla and O’Keefe, 2012; Anantharaju et al., 2016), butyrate exerted an anti-cancer function.